STE vs VTRS — Key Metrics
| Metric | STE (STERIS PLC) | VTRS (VIATRIS INC) |
|---|---|---|
| Price | 259.57 | 20.28 |
| Market Cap | 25.21 Billion | 23.25 Billion |
| P/E (TTM) | 30.68 | -38.26 |
| P/B (Quarterly) | 3.4 | 1.589 |
| P/S (TTM) | 4.09 | 1.58 |
| Net Profit Margin (TTM) | 13.4 | -4.1 |
| Gross Margin (TTM) | 44.6 | 35.3 |
| ROE (TTM) | 11.5 | -4.2 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Underperform
Greatly Outperform
Recommendation Summary
Stock STE is projected to greatly underperform the market, stock VTRS is projected to greatly outperform the market. Upfront Recommendation: VTRS.
Financial Metrics
| STE | Metrics | VTRS |
|---|---|---|
| $259.57 | Price | $20.28 |
| — | Market Capitalization | — |
| 4.09 | Price to Sales | 1.58 |
| 26.6 | Price to FCF Ratio | 10.85 |
| 9.17 | Price to Gross Profit | 4.47 |
| 212.89 | Price to R&D | 23.17 |
| 10.17 | Price to Current Assets | 2.26 |
STE vs VTRS at a glance
Steris PLC (STE) and Viatris INC (VTRS) are both in the Healthcare sector. They are similar in size: $25.2 billion and $23.3 billion in market value.
On trailing-twelve-month figures, STE trades at 4.1 times trailing sales and VTRS at 1.6; net profit margins are 13.4% and -4.1%.
The Upfront Investment model currently rates STE Greatly Underperform and VTRS Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.